Sector Update: Health-Care Shares Steady Ahead of Opening Bell
Top Health-care stocks:
Health-care shares were flat in pre-market trade Monday.
In health care stocks news, Regado BioSciences ( RGDO ) says it terminated enrollment in its REGULATE-PCI phase 3 trial for its lead program, Revolixys Kit, sending shares down more than 30% in pre-market trade.
The decision was made based on a recommendation from the trial's Data and Safety Monitoring Board following their analysis of the data from the first approximately 3250 patients enrolled in what was intended to be a 13,200-patient trial comparing the safety and efficacy of Revolixys Kit with bivalirudin, according to an SEC filing made by the company.
And, Biotechnology company InterMune ( ITMN ) shares soared more than 36% to $73.23, crashing through the top of the stock's 52-week regular session trading range of $10.95 - $55.24. Swiss pharmaceutical company Roche said it would acquire ITMN in an $8.3 billion deal.
The stock has been downgraded by analysts at Stifel Nicolaus to a hold rating from a buy. Price target information was not available.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.